407TiPPhase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600–mutant high-grade glioma (HGG) or low-grade glioma (LGG). (23rd October 2018) - Hargrave, D; Witt, O; Cohen, K; Packer, R; Lissat, A; Kordes, U; Laetsch, T W; Hoffman, L; Lassaletta, A; Gerber, N U; Gilheeney, S; Holm, S; et al.